Minzasolmin

Minzasolmin (development names DLX313 and UCB0599) is an experimental small-molecule drug in development for Parkinson's disease that is designed to prevent misfolding of α-synuclein.

See also

• Anti-α-synuclein drug
• List of investigational Parkinson's disease drugs

References